Predictors of failure on second-line antiretroviral therapy with protease inhibitor mutations in Uganda

INTRODUCTION: Failure on second-line antiretroviral therapy (ART) with protease inhibitor (PI) mutations (VF-M) is on the rise. However, there is a paucity of information on the factors associated with this observation in low-income countries. Knowledge of underlying factors is critical if we are to...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:AIDS Res Ther
Autors principals: Musana, Hellen, Ssensamba, Jude Thaddeus, Nakafeero, Mary, Mugerwa, Henry, Kiweewa, Flavia Matovu, Serwadda, David, Ssali, Francis
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2021
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8059285/
https://ncbi.nlm.nih.gov/pubmed/33882938
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12981-021-00338-y
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars